NMPA greenlights ZEISS ARTEVO 750 and 850, boosting China’s surgical visualization tech
ZEISS receives NMPA approval in China for ARTEVO 750 and 850 ophthalmic microscopes. Find out how these devices are shaping the future of eye surgery.
Tenacia’s ZTALMY launch shows new blueprint for orphan neurology drugs in China
ZTALMY gains commercial launch in China for CDKL5 seizures. Find out what this means for rare disease drug access and neurology strategy.
NMPA clears Zai Lab’s COBENFY, rewriting the schizophrenia treatment playbook
Zai Lab’s COBENFY approved in China as a first-in-class schizophrenia treatment. Find out what this milestone means for psychiatry and pharma innovation.
Can Peijia Medical’s TaurusTrio system finally solve the AR treatment gap in China?
Peijia Medical has received regulatory approval from the National Medical Products Administration of China for the TaurusTrio Transcatheter Aortic Valve system, a dedicated device for the treatment of native symptomatic severe aortic regurgitation. Developed under an exclusive license from JenaValve Technology, the system is based on the latter’s Trilogy Transcatheter Heart Valve platform and represents […]